Recurrence of gallstones after cholecystectomy is associated with ABCG5/8 genotype

Witigo von Schönfels1, Stephan Buch, Maren Wölk

  • 1Department of General and Thoracic Surgery, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Arnold-Heller-Str. 6, 24105, Kiel, Germany.

Insights

The ABCG8-D19H genetic variant is a significant predictor of gallstone recurrence after cholecystectomy, a common surgery. This finding highlights the role of sterolin transporters in gallstone formation.

Area of Science:

  • Gastroenterology
  • Genetics
  • Biliary System Physiology

Background:

  • Gallstone disease is a prevalent and costly condition, with cholecystectomy being a frequent surgical procedure worldwide.
  • Gallstone recurrence post-cholecystectomy can lead to serious complications like biliary sepsis and pancreatitis.
  • The ABCG8-D19H variant is recognized as a key genetic risk factor for gallstone disease.

Purpose of the Study:

  • To investigate the association between the ABCG8-D19H genetic variant and the recurrence of gallstones after cholecystectomy.
  • To determine if ABCG8-D19H is a significant predictor of long-term postoperative biliary complications.

Main Methods:

  • A cohort of 1,915 patients with available clinical and genetic data from a prior gallstone risk factor study was analyzed.
  • Symptomatic gallstone recurrence was defined as occurring more than six months post-surgery, with a median follow-up of eight years.
  • Multivariate logistic regression analysis was employed, adjusting for age, sex, BMI, and surgical type.

Main Results:

  • Gallstones recurred in 1.9% (37 patients) of the study cohort.
  • The ABCG8-D19H variant showed a significant association with gallstone recurrence (p = 0.034), with an allelic odds ratio of 1.97.
  • ABCG8-D19H remained a significant predictor in multivariate analyses (p = 0.024 in the total cohort, p = 0.020 in a subgroup).

Conclusions:

  • The ABCG8-D19H genetic variant is a significant predictor of gallstone recurrence following cholecystectomy.
  • This association underscores the importance of the sterolin transporter in the pathophysiology of gallstone formation.
  • Identifying genetic risk factors like ABCG8-D19H may aid in predicting and managing long-term postoperative biliary complications.
Abstract

Related Concept Videos

Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Gallbladder01:17

Gallbladder

The gallbladder is a small, pear-shaped organ that plays a crucial role in our digestive system. Measuring about 10 cm in length, it is comparable in size to a kiwi fruit and is located in a hollow area on the lower surface of the liver. The gallbladder's primary function is to store and concentrate bile, a fluid produced by the liver that aids in digestion.
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins the common...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...